VSee Health Secures $5M Equity Line at 15% Discount to Market Lows

summarizeSummary

VSee Health signed a $5 million equity line with Clearthink Capital Partners, priced at 85% of the lowest close over 10 days, with 40,000 commitment shares issued upfront.

check_boxKey Events · Financing and Capital Events · VSEEW

• $5M Equity Line with Clearthink

  VSee Health executed a Strata Purchase Agreement giving it the right, but not obligation, to sell up to $5.0 million of common stock to Clearthink Capital Partners over 36 months.

• Pricing at 15% Discount to 10-Day Low

  Each draw is priced at 85% of the lowest daily closing price during the 10 trading days preceding the purchase date — a structure that guarantees Clearthink a discount to recent market lows.

• 40,000 Commitment Fee Shares Issued

  Clearthink received 40,000 restricted shares upon signing, deemed earned regardless of whether the company ever draws on the facility.

• 9.99% Ownership Blocker

  Clearthink cannot be directed to purchase shares that would push its beneficial ownership above 9.99% of outstanding common stock.

auto_awesomeAnalysis · VSEEW · Industrial Applications And Services

VSee Health entered a $5 million equity line with Clearthink Capital Partners, priced at 85% of the lowest closing price over the prior 10 trading days. This is a deeply dilutive structure for a company already under a going-concern warning and Nasdaq delisting notice — the discount mechanism means each draw converts into shares at a price below recent market lows, and the 40,000 commitment fee shares are issued immediately regardless of whether the company ever draws. Against a market cap under $1 million, the $5 million commitment represents a potential multiple of the current share count, though actual dilution depends on how much the company draws and at what price. The company retains discretion over draws, but the terms reflect the high cost of capital available to a distressed issuer.